← Back to catalogue

2D Quantitative Analysis

FDA UDI

Class II (US FDA UDI)

by Philips Medical Systems Nederland B.V.

Identity

Trade Name
2D Quantitative Analysis FDA UDI
Generic Name
Angiographic x-ray system application software FDA UDI
Device Name
Software medical device, used with a Philips Interventional X-Ray System. Provides quantitative information about coronary arteries, peripheral arteries, and ventricles. FDA UDI
Model / Reference
2D Quantitative Analysis - 1 FDA UDI
Description
Software medical device, used with a Philips Interventional X-Ray System. Provides quantitative information about coronary arteries, peripheral arteries, and ventricles. FDA UDI

Identifiers

Catalog Number
001014 FDA UDI
Primary DI / UDI-DI
00884838075863 FDA UDI
510(k) Number
K161839 FDA UDI
FDA Product Code
OWB FDA UDI
LLZ FDA UDI
GMDN Term
Angiographic x-ray system application software FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
892.1650 FDA UDI
892.2050 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Angiographic x-ray system application software

2D Quantitative Analysis by Philips Medical Systems Nederland B.V. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Angiographic x-ray system application software.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 1fffc3a5-4206-44e6-bf58-85337ffa166f 35 fields · synced Sep 18, 2026